Japan Intractable Diseases Information Center. https://www.nanbyou.or.jp (Japanese)

Guidelines for the diagnosis and treatment of Werner syndrome. Yokote K, Takemoto M. Nippon Ronen Igakkai Zasshi 2013;50:417–427.(Japanese)

Takemoto M, Mori S, Kuzuya M, et al. Diagnostic criteria for Werner syndrome based on Japanese nationwide epidemiological survey. Geriatr Gerontol Int. 2013;13:475–81.

PubMed  Google Scholar 

Murata K, Nakashima H. Clinical and metabolic studies on Werner’s syndrome:with special reference to disorders of lipid and liver function. Adv Exp Med Biol. 1985;190:285–304.

CAS  PubMed  Google Scholar 

Mori S, Morisaki N, Murano S, et al. Fatty liver as a complication of patients with Werner’s syndrome. Jpn J Geriat 1988;25:626–631. (Japanese)

Lee J, Vail Y, Boursier J, et al. Prognostic accuracy of Fib-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int. 2021;41:261–70.

PubMed  PubMed Central  Google Scholar 

Singh S, Allen AM, Wang Z, et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13:643–54.; quiz e39–40.

Hashizume H, Sato K, Takagi H, et al. Werner syndrome as a possible cause of non-alcoholic steatohepatitis.J Clin Pathol 2009;62:1043–1045.

Imura H, Nakao Y, Kuzuya H, et al. Clinical, endocrine and metabolic aspects of the Werner syndrome compared with those of normal aging. Adv Exp Med Biol. 1985;190:171–85.

CAS  PubMed  Google Scholar 

Tsukamoto K, Takemoto M, Kubota Y, et al. Management guideline for Werner syndrome 2020 1. Dyslipidemia and fatty liver associated with Werner syndrome. Geriatr Gerontol Int 2021;21:133–138.

Sogawa M, Kasuya S, Yamamoto K, et al. Aortic valve replacement for aortic stenosis with a small aortic annulus in a patient having Werner’s syndrome and liver cirrhosis. Ann Thorac Cardiovasc Surg. 2001;7:378–80.

CAS  PubMed  Google Scholar 

Hakeem A, Reza S, Moinuddin S, et al. Cirrhosis in Werner’s syndrome: an unusual presentation of premature aging. Med Sci Monit 2007;13:CS61–66.

Amalnath SD, Sargolzaeiaval F, Oshima J, et al. Uncommon cause of cirrhosis: a case of Werner syndrome with a novel WRN mutation. Indian J Gastroenterol. 2017;36:323–5.

PubMed  PubMed Central  Google Scholar 

Kuzuya M, Shi RQ, Yanagawa M, et al. Long-lived Werner syndrome patient autopsy report: the presence of liver cirrhosis. Geriatr Gerontol Int. 2021;21:433–5.

PubMed  Google Scholar 

Yu CE, Oshima J, Fu YH, et al. Positional cloning of the Werner’s syndrome gene. Science. 1996;272:258–62.

CAS  PubMed  Google Scholar 

Maezawa Y. Basic science of Werner syndrome. Jpn J Geriat 2021;58:402–408. (Japanese)

Shamanna RA, Lu H, de Freitas JK, Tian J et al. WRN regulates pathway choice between classical and alternative non-homologus end joining. Nature Commun. 7:13785.

Tokita M, Kennedy SR, Risques RA et al. Werner syndrome through the lens of tissue and tumour genomics. Sci Rep. 6:32038.

Kato H, Maezawa Y, Takayama N, et al. Fibroblasts from different body parts exhibit distinct phenotypes in adult progeria Werner syndrome. Aging (Albany NY). 2021;13:4946–61.

CAS  PubMed  Google Scholar 

Tu J, Wan C, Zhang F, et al. Genetic correction of Werner syndrome gene reveals impaired pro-angiogemic function and HGF insufficiency in mesenchymal stem cells. Aging Cell 2020;19:e13116.

Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. J Gastroenterol. 2021;56:951–63.

PubMed  PubMed Central  Google Scholar 

Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol. 2021;56:593–619.

PubMed  PubMed Central  Google Scholar 

Belfort R, Harrison SA, Brown K, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Eng J Med. 2006;355:2297–307.

CAS  Google Scholar 

The Japanese Society of Gastroenterology, The Japanese Society of Hepatology. Evidence-based Clinical Practice Guidelines for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis 2020 (2nd edition). (Japanese)

Takemoto M, Yamaga M, Furuichi Y, et al. Astaxanthin improves nonalcoholic fatty liver disease in Werner syndrome with diabetes mellitus. J Am Geriatr Soc. 2015;63:1271–3.

PubMed  Google Scholar